Economic impact of biosimilar drugs in Italy: past, present and future of infliximab and etanercept
Economic impact of biosimilar drugs in Italy: past, present and future of infliximab and etanerceptPurposeThe objective of this study is to estimate the impact of the Anti-TNF monoclonal antibodies that are currently approved in Italy (etanercept ed infliximab) on healthcare expenditure between 2014...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2017-07-01
|
| Series: | Global & Regional Health Technology Assessment |
| Online Access: | http://www.grhta.com/Attach/70C92971-2D3D-4F4C-BD39-BA86DCE5A16F/F7516D34-2571-4BA0-8764-00E0164A0B6C |